<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03578419</url>
  </required_header>
  <id_info>
    <org_study_id>STRATUS</org_study_id>
    <nct_id>NCT03578419</nct_id>
  </id_info>
  <brief_title>Small-Volume Tubes to Reduce Anemia and Transfusion</brief_title>
  <acronym>STRATUS</acronym>
  <official_title>Small-Volume Tubes to Reduce Anemia and Transfusion: A Pragmatic Stepped Wedge Cluster Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Population Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Population Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      STRATUS will evaluate the use of small-volume (&quot;soft-draw&quot;) blood collection tubes for
      laboratory testing in reducing anemia and transfusion in intensive care unit patients without
      significant adverse consequences. This is a simple, cost-neutral intervention that could
      improve the quality of patient care and reduce the harms of frequent laboratory testing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Blood sampling can cause significant unnecessary blood loss particularly in the intensive
      care unit (ICU). Blood loss contributes to anemia which is highly prevalent in the ICU and is
      associated with major adverse cardiovascular outcomes and death. Red blood cell (RBC)
      transfusions to correct anemia also have significant health risks.

      Using a stepped wedge cluster randomized trial design, the specific aim of the STRATUS study
      is to evaluate whether the routine use of small-volume blood collection tubes reduces RBC
      transfusion compared to standard-volume blood collection tubes in adult ICU patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>A stepped wedge cluster randomized trial in which ICUs (clusters) switch from a strategy of blood collection using standard-draw tubes (control) to soft-draw tubes (intervention). In this design, the timing at which individual ICUs switch to the intervention is randomly assigned.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>RBC Transfusions</measure>
    <time_frame>through study completion, an average of 1.5 years</time_frame>
    <description>Average number of red blood cell (RBC) units transfused per patient during ICU admission among patients admitted to ICU for 48 hours or longer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin Concentration</measure>
    <time_frame>through study completion, an average of 1.5 years</time_frame>
    <description>Change in hemoglobin concentration from ICU admission to ICU discharge adjusted for number of RBC transfusions received</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU and hospital length of stay</measure>
    <time_frame>through study completion, an average of 1.5 years</time_frame>
    <description>Length of stay in the ICU and hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU and hospital mortality</measure>
    <time_frame>through study completion, an average of 1.5 years</time_frame>
    <description>Mortality rates in the ICU and hospital</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Blood Loss Anemia</condition>
  <arm_group>
    <arm_group_label>Control Period</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard-Volume Blood Collection Tubes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention Period</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Small-Volume Blood Collection Tubes (&quot;soft-draw&quot;)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Small-Volume Blood Collection Tubes</intervention_name>
    <description>Small-volume vacuum (&lt; 4 mL) ethylenediaminetetraacetic acid (EDTA), lithium-heparin, citrate, fluoride and serum blood collection tubes.</description>
    <arm_group_label>Intervention Period</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard-Volume Blood Collection Tubes</intervention_name>
    <description>Standard-volume (â‰¥ 4 mL) ethylenediaminetetraacetic acid (EDTA), lithium-heparin, citrate, fluoride and serum blood collection tubes.</description>
    <arm_group_label>Control Period</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        ICUs will be eligible if they meet the following criteria:

          1. Adult ICU

          2. At least 14 level 2-3 ICU beds with capacity for invasive mechanical ventilation

          3. Use of vacuum tubes for routine blood collection

          4. Able to achieve at least 25% estimated reduction in blood volume by switching to
             small-volume vacuum tubes

          5. Electronic administrative and health record data available for data collection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deborah Siegal, MD MSc FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Population Health Research Institute; McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stuart Connolly, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Population Health Research Institute; McMaster University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>STRATUS Coordinator</last_name>
    <phone>9055212100</phone>
    <phone_ext>40329</phone_ext>
    <email>stratus@phri.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stratus Study Coordinator, MD</last_name>
      <phone>9055212100</phone>
      <email>stratus@phri.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>June 21, 2018</study_first_submitted>
  <study_first_submitted_qc>July 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2018</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anemia</keyword>
  <keyword>Blood transfusion</keyword>
  <keyword>Intensive Care Unit</keyword>
  <keyword>Blood sampling</keyword>
  <keyword>Stepped wedge</keyword>
  <keyword>Red blood cells</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

